Prevalence and clinical impact of frailty in COPD: a systematic review and meta-analysis
Frailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and impact of frailty on health outcomes in people with COPD require clarification. PubMed, Embase, The Cochrane Library and Web of Science (January 1, 2002,...
Saved in:
| Published in | BMC pulmonary medicine Vol. 23; no. 1; pp. 164 - 12 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
12.05.2023
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Frailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and impact of frailty on health outcomes in people with COPD require clarification.
PubMed, Embase, The Cochrane Library and Web of Science (January 1, 2002, to July 1, 2022) were comprehensively searched to identify studies related to frailty and COPD. Comparisons were made between people who did and did not have frailty for pulmonary function, dyspnea severity, 6-minute walking distance, activities of daily life, and mortality.
Twenty studies (9 cross-sectional, 10 cohort studies,1 clinical trial) from Europe (9), Asia (6), and North and South America (4), Oceania (1) involving 11, 620 participants were included. The prevalence of frailty was 32.07% (95% confidence interval (CI) 26.64-37.49) with a range of 6.43-71.70% based on the frailty tool used. People with frailty had lower predicted forced expiratory volume in the first second (mean difference - 5.06%; 95%CI -6.70 to -3.42%), shorter 6-minute walking distance (mean difference - 90.23 m; 95%CI -124.70 to -55.76), poorer activities of daily life (standardized mean difference - 0.99; 95%CI -1.35 to -0.62), higher CAT(COPD Assessment Test) score(mean difference 6.2; 95%CI 4.43 to 7.96) and mMRC (modified Medical Research Council) grade (mean difference 0.93; 95%CI 0.85 to 1.02) compared with those who did not (P < 0.001 for all). Meta-analysis showed that frailty was associated with an increased risk of long-term all-cause mortality (HR 1.68; 95% CI 1.37-2.05; I
= 0%, P < 0.001).
Frailty is prevalent in people with COPD and linked with negative clinical outcomes including pulmonary function, dyspnea severity, exercise capacity, quality of life and mortality. |
|---|---|
| AbstractList | BackgroundFrailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and impact of frailty on health outcomes in people with COPD require clarification.MethodsPubMed, Embase, The Cochrane Library and Web of Science (January 1, 2002, to July 1, 2022) were comprehensively searched to identify studies related to frailty and COPD. Comparisons were made between people who did and did not have frailty for pulmonary function, dyspnea severity, 6-minute walking distance, activities of daily life, and mortality.ResultsTwenty studies (9 cross-sectional, 10 cohort studies,1 clinical trial) from Europe (9), Asia (6), and North and South America (4), Oceania (1) involving 11, 620 participants were included. The prevalence of frailty was 32.07% (95% confidence interval (CI) 26.64–37.49) with a range of 6.43–71.70% based on the frailty tool used. People with frailty had lower predicted forced expiratory volume in the first second (mean difference − 5.06%; 95%CI -6.70 to -3.42%), shorter 6-minute walking distance (mean difference − 90.23 m; 95%CI -124.70 to -55.76), poorer activities of daily life (standardized mean difference − 0.99; 95%CI -1.35 to -0.62), higher CAT(COPD Assessment Test) score(mean difference 6.2; 95%CI 4.43 to 7.96) and mMRC (modified Medical Research Council) grade (mean difference 0.93; 95%CI 0.85 to 1.02) compared with those who did not (P < 0.001 for all). Meta-analysis showed that frailty was associated with an increased risk of long-term all-cause mortality (HR 1.68; 95% CI 1.37–2.05; I2 = 0%, P < 0.001).ConclusionFrailty is prevalent in people with COPD and linked with negative clinical outcomes including pulmonary function, dyspnea severity, exercise capacity, quality of life and mortality. Frailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and impact of frailty on health outcomes in people with COPD require clarification. PubMed, Embase, The Cochrane Library and Web of Science (January 1, 2002, to July 1, 2022) were comprehensively searched to identify studies related to frailty and COPD. Comparisons were made between people who did and did not have frailty for pulmonary function, dyspnea severity, 6-minute walking distance, activities of daily life, and mortality. Twenty studies (9 cross-sectional, 10 cohort studies,1 clinical trial) from Europe (9), Asia (6), and North and South America (4), Oceania (1) involving 11, 620 participants were included. The prevalence of frailty was 32.07% (95% confidence interval (CI) 26.64-37.49) with a range of 6.43-71.70% based on the frailty tool used. People with frailty had lower predicted forced expiratory volume in the first second (mean difference - 5.06%; 95%CI -6.70 to -3.42%), shorter 6-minute walking distance (mean difference - 90.23 m; 95%CI -124.70 to -55.76), poorer activities of daily life (standardized mean difference - 0.99; 95%CI -1.35 to -0.62), higher CAT(COPD Assessment Test) score(mean difference 6.2; 95%CI 4.43 to 7.96) and mMRC (modified Medical Research Council) grade (mean difference 0.93; 95%CI 0.85 to 1.02) compared with those who did not (P < 0.001 for all). Meta-analysis showed that frailty was associated with an increased risk of long-term all-cause mortality (HR 1.68; 95% CI 1.37-2.05; I = 0%, P < 0.001). Frailty is prevalent in people with COPD and linked with negative clinical outcomes including pulmonary function, dyspnea severity, exercise capacity, quality of life and mortality. Frailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and impact of frailty on health outcomes in people with COPD require clarification. PubMed, Embase, The Cochrane Library and Web of Science (January 1, 2002, to July 1, 2022) were comprehensively searched to identify studies related to frailty and COPD. Comparisons were made between people who did and did not have frailty for pulmonary function, dyspnea severity, 6-minute walking distance, activities of daily life, and mortality. Twenty studies (9 cross-sectional, 10 cohort studies,1 clinical trial) from Europe (9), Asia (6), and North and South America (4), Oceania (1) involving 11, 620 participants were included. The prevalence of frailty was 32.07% (95% confidence interval (CI) 26.64-37.49) with a range of 6.43-71.70% based on the frailty tool used. People with frailty had lower predicted forced expiratory volume in the first second (mean difference - 5.06%; 95%CI -6.70 to -3.42%), shorter 6-minute walking distance (mean difference - 90.23 m; 95%CI -124.70 to -55.76), poorer activities of daily life (standardized mean difference - 0.99; 95%CI -1.35 to -0.62), higher CAT(COPD Assessment Test) score(mean difference 6.2; 95%CI 4.43 to 7.96) and mMRC (modified Medical Research Council) grade (mean difference 0.93; 95%CI 0.85 to 1.02) compared with those who did not (P < 0.001 for all). Meta-analysis showed that frailty was associated with an increased risk of long-term all-cause mortality (HR 1.68; 95% CI 1.37-2.05; I.sup.2 = 0%, P < 0.001). Frailty is prevalent in people with COPD and linked with negative clinical outcomes including pulmonary function, dyspnea severity, exercise capacity, quality of life and mortality. Background Frailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and impact of frailty on health outcomes in people with COPD require clarification. Methods PubMed, Embase, The Cochrane Library and Web of Science (January 1, 2002, to July 1, 2022) were comprehensively searched to identify studies related to frailty and COPD. Comparisons were made between people who did and did not have frailty for pulmonary function, dyspnea severity, 6-minute walking distance, activities of daily life, and mortality. Results Twenty studies (9 cross-sectional, 10 cohort studies,1 clinical trial) from Europe (9), Asia (6), and North and South America (4), Oceania (1) involving 11, 620 participants were included. The prevalence of frailty was 32.07% (95% confidence interval (CI) 26.64-37.49) with a range of 6.43-71.70% based on the frailty tool used. People with frailty had lower predicted forced expiratory volume in the first second (mean difference - 5.06%; 95%CI -6.70 to -3.42%), shorter 6-minute walking distance (mean difference - 90.23 m; 95%CI -124.70 to -55.76), poorer activities of daily life (standardized mean difference - 0.99; 95%CI -1.35 to -0.62), higher CAT(COPD Assessment Test) score(mean difference 6.2; 95%CI 4.43 to 7.96) and mMRC (modified Medical Research Council) grade (mean difference 0.93; 95%CI 0.85 to 1.02) compared with those who did not (P < 0.001 for all). Meta-analysis showed that frailty was associated with an increased risk of long-term all-cause mortality (HR 1.68; 95% CI 1.37-2.05; I.sup.2 = 0%, P < 0.001). Conclusion Frailty is prevalent in people with COPD and linked with negative clinical outcomes including pulmonary function, dyspnea severity, exercise capacity, quality of life and mortality. Keywords: Chronic obstructive pulmonary disease, Frailty, Mortality, Prevalence, meta-analysis Abstract Background Frailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and impact of frailty on health outcomes in people with COPD require clarification. Methods PubMed, Embase, The Cochrane Library and Web of Science (January 1, 2002, to July 1, 2022) were comprehensively searched to identify studies related to frailty and COPD. Comparisons were made between people who did and did not have frailty for pulmonary function, dyspnea severity, 6-minute walking distance, activities of daily life, and mortality. Results Twenty studies (9 cross-sectional, 10 cohort studies,1 clinical trial) from Europe (9), Asia (6), and North and South America (4), Oceania (1) involving 11, 620 participants were included. The prevalence of frailty was 32.07% (95% confidence interval (CI) 26.64–37.49) with a range of 6.43–71.70% based on the frailty tool used. People with frailty had lower predicted forced expiratory volume in the first second (mean difference − 5.06%; 95%CI -6.70 to -3.42%), shorter 6-minute walking distance (mean difference − 90.23 m; 95%CI -124.70 to -55.76), poorer activities of daily life (standardized mean difference − 0.99; 95%CI -1.35 to -0.62), higher CAT(COPD Assessment Test) score(mean difference 6.2; 95%CI 4.43 to 7.96) and mMRC (modified Medical Research Council) grade (mean difference 0.93; 95%CI 0.85 to 1.02) compared with those who did not (P < 0.001 for all). Meta-analysis showed that frailty was associated with an increased risk of long-term all-cause mortality (HR 1.68; 95% CI 1.37–2.05; I 2 = 0%, P < 0.001). Conclusion Frailty is prevalent in people with COPD and linked with negative clinical outcomes including pulmonary function, dyspnea severity, exercise capacity, quality of life and mortality. Frailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and impact of frailty on health outcomes in people with COPD require clarification.BACKGROUNDFrailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and impact of frailty on health outcomes in people with COPD require clarification.PubMed, Embase, The Cochrane Library and Web of Science (January 1, 2002, to July 1, 2022) were comprehensively searched to identify studies related to frailty and COPD. Comparisons were made between people who did and did not have frailty for pulmonary function, dyspnea severity, 6-minute walking distance, activities of daily life, and mortality.METHODSPubMed, Embase, The Cochrane Library and Web of Science (January 1, 2002, to July 1, 2022) were comprehensively searched to identify studies related to frailty and COPD. Comparisons were made between people who did and did not have frailty for pulmonary function, dyspnea severity, 6-minute walking distance, activities of daily life, and mortality.Twenty studies (9 cross-sectional, 10 cohort studies,1 clinical trial) from Europe (9), Asia (6), and North and South America (4), Oceania (1) involving 11, 620 participants were included. The prevalence of frailty was 32.07% (95% confidence interval (CI) 26.64-37.49) with a range of 6.43-71.70% based on the frailty tool used. People with frailty had lower predicted forced expiratory volume in the first second (mean difference - 5.06%; 95%CI -6.70 to -3.42%), shorter 6-minute walking distance (mean difference - 90.23 m; 95%CI -124.70 to -55.76), poorer activities of daily life (standardized mean difference - 0.99; 95%CI -1.35 to -0.62), higher CAT(COPD Assessment Test) score(mean difference 6.2; 95%CI 4.43 to 7.96) and mMRC (modified Medical Research Council) grade (mean difference 0.93; 95%CI 0.85 to 1.02) compared with those who did not (P < 0.001 for all). Meta-analysis showed that frailty was associated with an increased risk of long-term all-cause mortality (HR 1.68; 95% CI 1.37-2.05; I2 = 0%, P < 0.001).RESULTSTwenty studies (9 cross-sectional, 10 cohort studies,1 clinical trial) from Europe (9), Asia (6), and North and South America (4), Oceania (1) involving 11, 620 participants were included. The prevalence of frailty was 32.07% (95% confidence interval (CI) 26.64-37.49) with a range of 6.43-71.70% based on the frailty tool used. People with frailty had lower predicted forced expiratory volume in the first second (mean difference - 5.06%; 95%CI -6.70 to -3.42%), shorter 6-minute walking distance (mean difference - 90.23 m; 95%CI -124.70 to -55.76), poorer activities of daily life (standardized mean difference - 0.99; 95%CI -1.35 to -0.62), higher CAT(COPD Assessment Test) score(mean difference 6.2; 95%CI 4.43 to 7.96) and mMRC (modified Medical Research Council) grade (mean difference 0.93; 95%CI 0.85 to 1.02) compared with those who did not (P < 0.001 for all). Meta-analysis showed that frailty was associated with an increased risk of long-term all-cause mortality (HR 1.68; 95% CI 1.37-2.05; I2 = 0%, P < 0.001).Frailty is prevalent in people with COPD and linked with negative clinical outcomes including pulmonary function, dyspnea severity, exercise capacity, quality of life and mortality.CONCLUSIONFrailty is prevalent in people with COPD and linked with negative clinical outcomes including pulmonary function, dyspnea severity, exercise capacity, quality of life and mortality. |
| ArticleNumber | 164 |
| Audience | Academic |
| Author | Wang, Lina Liu, Xinmin Zhang, Xiaolin |
| Author_xml | – sequence: 1 givenname: Lina surname: Wang fullname: Wang, Lina – sequence: 2 givenname: Xiaolin surname: Zhang fullname: Zhang, Xiaolin – sequence: 3 givenname: Xinmin surname: Liu fullname: Liu, Xinmin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37173728$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktv1DAUhSNURB_wB1igSGzYpPgV22GDquFVqVK7AImddce5GTxy7GJniqa_Hs9MKZ0KISuydfOdE9-bc1wdhBiwql5Sckqplm8zZbojDWG8PKIVze2T6ogKRRsmpDx4cD6sjnNeEkKVbvmz6pArqrhi-qj6fpXwBjwGizWEvrbeBWfB1268BjvVcaiHBM5P69qFenZ59eFdDXVe5wlHmJyti9zhr612xAkaCODX2eXn1dMBfMYXd_tJ9e3Tx6-zL83F5efz2dlFYyUnU6Na4EzPSavBko71EjpkoFkPtFNSEKqZpgJkhxa6bhCcoJJcc5jPB2wHwk-q851vH2FprpMbIa1NBGe2hZgWBlK5qEcjUPVK9MitAjFoPVeSMsvZQHVbBtkWr_c7r-vVfMTeYpgS-D3T_TfB_TCLeGPo5p5SdcXhzZ1Dij9XmCczumzRewgYV9mUZnjbdlLqgr5-hC7jKpXpbakCCSbUX2pRfpJxYYjlw3Zjas6U6CjRUstCnf6DKqvH0dmSmsGV-p7g1cNO71v8E4wCsB1gU8w54XCPUGI26TO79JmSPrNNn7ktIv1IZN1UUhI303L-f9Lf1JjcBw |
| CitedBy_id | crossref_primary_10_1016_j_rmclc_2024_05_009 crossref_primary_10_54803_sauhsd_1435079 crossref_primary_10_1016_j_pccm_2025_02_002 crossref_primary_10_1111_jgs_19268 crossref_primary_10_1186_s40001_024_01685_y crossref_primary_10_2147_COPD_S444580 crossref_primary_10_1007_s00391_025_02409_5 crossref_primary_10_1093_europace_euae021 crossref_primary_10_2147_COPD_S501635 crossref_primary_10_2147_COPD_S485017 crossref_primary_10_3390_jcm13040984 crossref_primary_10_1186_s12890_024_02967_1 crossref_primary_10_3390_jcm13020585 crossref_primary_10_1016_j_archger_2023_105310 crossref_primary_10_1111_jgs_19423 crossref_primary_10_1177_14799731231196582 crossref_primary_10_1016_j_heliyon_2024_e25750 crossref_primary_10_1055_s_0044_1801349 crossref_primary_10_2147_COPD_S455316 crossref_primary_10_1016_j_rmed_2024_107778 crossref_primary_10_1016_j_regg_2024_101565 |
| Cites_doi | 10.1177/1479973119867954 10.1080/15412555.2021.1967915 10.1186/s12979-022-00306-8 10.1007/s40520-021-01878-z 10.1093/gerona/glv154 10.1136/bmjresp-2022-001314 10.1177/1753465817726314 10.1177/0962280216669183 10.1016/j.archger.2022.104658 10.1080/15412555.2021.1975670 10.1136/bmjresp-2017-000196 10.1513/AnnalsATS.201612-1008OC 10.1503/cmaj.050051 10.1136/bmj.d6553 10.1093/gerona/56.3.M146 10.1513/AnnalsATS.201803-175OC 10.1136/bmj.d5928 10.1136/thoraxjnl-2016-208460 10.1016/j.chest.2018.02.014 10.1177/1479972317752763 10.2147/COPD.S250299 10.1016/j.arr.2016.08.006 10.1001/jama.2013.5732 10.1186/s12931-022-02084-9 10.1093/ageing/afad004 10.2147/COPD.S245505 10.1016/j.amjmed.2005.10.049 10.1016/j.jamda.2020.09.033 10.7326/0003-4819-142-12_Part_2-200506211-00002 10.2147/COPD.S295885 10.1111/ggi.13740 10.1007/s10654-010-9491-z 10.1016/j.jamda.2017.10.006 10.1007/s11845-021-02654-8 10.1186/s12955-018-0969-9 10.1016/j.arr.2022.101652 10.1159/000381134 10.2147/CIA.S303852 10.1016/S0140-6736(19)31785-4 10.1016/j.arr.2022.101656 10.1016/j.jamda.2018.06.009 10.1186/1471-2288-14-135 10.1001/jamacardio.2019.3511 10.1136/bmj.n71 10.1007/BF03351076 10.1016/j.apnr.2021.151417 |
| ContentType | Journal Article |
| Copyright | 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2023 |
| Copyright_xml | – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2023 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s12890-023-02454-z |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2466 |
| EndPage | 12 |
| ExternalDocumentID | oai_doaj_org_article_4e7d74de3c7a4f88b7612c32f1858905 PMC10182679 A749108686 37173728 10_1186_s12890_023_02454_z |
| Genre | Meta-Analysis Systematic Review Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GrantInformation_xml | – fundername: National Key R&D Program of China grantid: 2020YFC2008804 – fundername: ; grantid: 2020YFC2008804; 2020YFC2008804; 2020YFC2008804 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7TO 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c630t-75a328b058ac092d6a9e2a82da197640182814a69eca99f430e76383abbfe5f03 |
| IEDL.DBID | M48 |
| ISSN | 1471-2466 |
| IngestDate | Wed Aug 27 01:32:44 EDT 2025 Thu Aug 21 18:37:27 EDT 2025 Mon Jul 21 09:20:53 EDT 2025 Sat Jul 26 00:16:13 EDT 2025 Tue Jun 17 20:59:32 EDT 2025 Tue Jun 10 20:47:05 EDT 2025 Thu Jan 02 22:51:50 EST 2025 Thu Apr 24 23:07:19 EDT 2025 Tue Jul 01 02:40:32 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | meta-analysis Frailty Chronic obstructive pulmonary disease Prevalence Mortality |
| Language | English |
| License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c630t-75a328b058ac092d6a9e2a82da197640182814a69eca99f430e76383abbfe5f03 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12890-023-02454-z |
| PMID | 37173728 |
| PQID | 2815594247 |
| PQPubID | 44785 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_4e7d74de3c7a4f88b7612c32f1858905 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10182679 proquest_miscellaneous_2813559668 proquest_journals_2815594247 gale_infotracmisc_A749108686 gale_infotracacademiconefile_A749108686 pubmed_primary_37173728 crossref_primary_10_1186_s12890_023_02454_z crossref_citationtrail_10_1186_s12890_023_02454_z |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-05-12 |
| PublicationDateYYYYMMDD | 2023-05-12 |
| PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-12 day: 12 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC pulmonary medicine |
| PublicationTitleAlternate | BMC Pulm Med |
| PublicationYear | 2023 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | H Kundi (2454_CR4) 2019; 4 M Thomsen (2454_CR41) 2013; 309 P Finamore (2454_CR22) 2021; 18 M Kusunose (2454_CR27) 2017; 4 P Soysal (2454_CR39) 2016; 31 MJ Page (2454_CR16) 2021; 372 A Stang (2454_CR17) 2010; 25 LP Fried (2454_CR2) 2001; 56 S Gephine (2454_CR25) 2021; 16 K Hirai (2454_CR28) 2019; 19 S Scarlata (2454_CR33) 2021; 33 NS Gale (2454_CR26) 2018; 15 M Proietti (2454_CR7) 2022; 79 2454_CR40 N Yee (2454_CR13) 2020; 15 S Gephine (2454_CR46) 2022; 9 Y Hong (2454_CR42) 2022; 23 F Mei (2454_CR5) 2021; 22 T Fulop (2454_CR37) 2015; 41 H Zhang (2454_CR6) 2022; 79 CC Kennedy (2454_CR10) 2019; 16 E Naval (2454_CR24) 2021; 18 O Pansarasa (2454_CR38) 2022; 19 A Marengoni (2454_CR9) 2018; 154 G Galizia (2454_CR34) 2011; 23 K Rockwood (2454_CR3) 2005; 173 Y Zhang (2454_CR8) 2018; 19 2454_CR15 E Dent (2454_CR1) 2019; 394 L Lahousse (2454_CR31) 2016; 71 JP Higgins (2454_CR19) 2011; 343 G Ellis (2454_CR47) 2011; 343 K Ushida (2454_CR12) 2022; 100 X Wan (2454_CR21) 2014; 14 S Kagiali (2454_CR23) 2022; 191 2454_CR30 D Atkins (2454_CR18) 2005; 142 M Maddocks (2454_CR29) 2016; 71 SK Park (2454_CR36) 2021; 59 MR Baldwin (2454_CR44) 2017; 14 J Luo (2454_CR11) 2021; 16 D Luo (2454_CR20) 2018; 27 VM McDonald (2454_CR45) 2019; 16 LS Dias (2454_CR35) 2020; 15 R Bernabeu-Mora (2454_CR14) 2017; 11 F Medina-Mirapeix (2454_CR32) 2018; 16 E Chong (2454_CR43) 2018; 19 |
| References_xml | – volume: 16 start-page: 147997311986795 year: 2019 ident: 2454_CR45 publication-title: Chron Respir Dis doi: 10.1177/1479973119867954 – volume: 18 start-page: 518 issue: 5 year: 2021 ident: 2454_CR22 publication-title: COPD doi: 10.1080/15412555.2021.1967915 – volume: 19 start-page: 49 issue: 1 year: 2022 ident: 2454_CR38 publication-title: Immun Ageing doi: 10.1186/s12979-022-00306-8 – volume: 33 start-page: 2165 issue: 8 year: 2021 ident: 2454_CR33 publication-title: Aging Clin Exp Res doi: 10.1007/s40520-021-01878-z – volume: 71 start-page: 689 issue: 5 year: 2016 ident: 2454_CR31 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/glv154 – ident: 2454_CR30 doi: 10.1136/bmjresp-2022-001314 – volume: 11 start-page: 383 issue: 10 year: 2017 ident: 2454_CR14 publication-title: Ther Adv Respir Dis doi: 10.1177/1753465817726314 – volume: 27 start-page: 1785 issue: 6 year: 2018 ident: 2454_CR20 publication-title: Stat Methods Med Res doi: 10.1177/0962280216669183 – volume: 100 start-page: 104658 year: 2022 ident: 2454_CR12 publication-title: Arch Gerontol Geriatr doi: 10.1016/j.archger.2022.104658 – volume: 18 start-page: 525 issue: 5 year: 2021 ident: 2454_CR24 publication-title: COPD doi: 10.1080/15412555.2021.1975670 – volume: 4 start-page: e000196 issue: 1 year: 2017 ident: 2454_CR27 publication-title: BMJ Open Respir Res doi: 10.1136/bmjresp-2017-000196 – volume: 14 start-page: 1270 issue: 8 year: 2017 ident: 2454_CR44 publication-title: Ann Am Thorac Soc doi: 10.1513/AnnalsATS.201612-1008OC – volume: 173 start-page: 489 issue: 5 year: 2005 ident: 2454_CR3 publication-title: CMAJ doi: 10.1503/cmaj.050051 – volume: 343 start-page: d6553 year: 2011 ident: 2454_CR47 publication-title: BMJ doi: 10.1136/bmj.d6553 – volume: 9 start-page: 15 issue: 1 year: 2022 ident: 2454_CR46 publication-title: Chronic Obstr Pulm Dis – volume: 56 start-page: M146-156 issue: 3 year: 2001 ident: 2454_CR2 publication-title: J Gerontol A Biol Sci Med Sci doi: 10.1093/gerona/56.3.M146 – volume: 16 start-page: 217 issue: 2 year: 2019 ident: 2454_CR10 publication-title: Annals of the American Thoracic Society doi: 10.1513/AnnalsATS.201803-175OC – volume: 343 start-page: d5928 year: 2011 ident: 2454_CR19 publication-title: BMJ doi: 10.1136/bmj.d5928 – volume: 71 start-page: 988 issue: 11 year: 2016 ident: 2454_CR29 publication-title: Thorax doi: 10.1136/thoraxjnl-2016-208460 – volume: 154 start-page: 21 issue: 1 year: 2018 ident: 2454_CR9 publication-title: Chest doi: 10.1016/j.chest.2018.02.014 – volume: 15 start-page: 347 issue: 4 year: 2018 ident: 2454_CR26 publication-title: Chron Respir Dis doi: 10.1177/1479972317752763 – volume: 15 start-page: 1349 year: 2020 ident: 2454_CR35 publication-title: International Journal of COPD doi: 10.2147/COPD.S250299 – volume: 31 start-page: 1 year: 2016 ident: 2454_CR39 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2016.08.006 – volume: 309 start-page: 2353 issue: 22 year: 2013 ident: 2454_CR41 publication-title: JAMA doi: 10.1001/jama.2013.5732 – volume: 23 start-page: 166 issue: 1 year: 2022 ident: 2454_CR42 publication-title: Respir Res doi: 10.1186/s12931-022-02084-9 – ident: 2454_CR15 doi: 10.1093/ageing/afad004 – volume: 15 start-page: 1967 year: 2020 ident: 2454_CR13 publication-title: Int J Chron Obstruct Pulmon Dis doi: 10.2147/COPD.S245505 – ident: 2454_CR40 doi: 10.1016/j.amjmed.2005.10.049 – volume: 22 start-page: 535 issue: 3 year: 2021 ident: 2454_CR5 publication-title: Journal of the American Medical Directors Association doi: 10.1016/j.jamda.2020.09.033 – volume: 142 start-page: 1035 issue: 12 Pt 2 year: 2005 ident: 2454_CR18 publication-title: Ann Intern Med doi: 10.7326/0003-4819-142-12_Part_2-200506211-00002 – volume: 16 start-page: 1381 year: 2021 ident: 2454_CR25 publication-title: Int J Chron Obstruct Pulmon Dis doi: 10.2147/COPD.S295885 – volume: 19 start-page: 896 issue: 9 year: 2019 ident: 2454_CR28 publication-title: Geriatr Gerontol Int doi: 10.1111/ggi.13740 – volume: 25 start-page: 603 issue: 9 year: 2010 ident: 2454_CR17 publication-title: Eur J Epidemiol doi: 10.1007/s10654-010-9491-z – volume: 19 start-page: 450 issue: 5 year: 2018 ident: 2454_CR43 publication-title: Journal of the American Medical Directors Association doi: 10.1016/j.jamda.2017.10.006 – volume: 191 start-page: 817 issue: 2 year: 2022 ident: 2454_CR23 publication-title: Ir J Med Sci doi: 10.1007/s11845-021-02654-8 – volume: 16 start-page: 140 issue: 1 year: 2018 ident: 2454_CR32 publication-title: Health Qual Life Outcomes doi: 10.1186/s12955-018-0969-9 – volume: 79 start-page: 101652 year: 2022 ident: 2454_CR7 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2022.101652 – volume: 41 start-page: 26 year: 2015 ident: 2454_CR37 publication-title: Interdiscip Top Gerontol Geriatr doi: 10.1159/000381134 – volume: 16 start-page: 593 year: 2021 ident: 2454_CR11 publication-title: Clin Interv Aging doi: 10.2147/CIA.S303852 – volume: 394 start-page: 1376 issue: 10206 year: 2019 ident: 2454_CR1 publication-title: Lancet (London, England) doi: 10.1016/S0140-6736(19)31785-4 – volume: 79 start-page: 101656 year: 2022 ident: 2454_CR6 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2022.101656 – volume: 19 start-page: 1003 issue: 11 year: 2018 ident: 2454_CR8 publication-title: Journal of the American Medical Directors Association doi: 10.1016/j.jamda.2018.06.009 – volume: 14 start-page: 135 year: 2014 ident: 2454_CR21 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-135 – volume: 4 start-page: 1084 issue: 11 year: 2019 ident: 2454_CR4 publication-title: JAMA cardiology doi: 10.1001/jamacardio.2019.3511 – volume: 372 start-page: n71 year: 2021 ident: 2454_CR16 publication-title: BMJ doi: 10.1136/bmj.n71 – volume: 23 start-page: 118 issue: 2 year: 2011 ident: 2454_CR34 publication-title: Aging Clin Exp Res doi: 10.1007/BF03351076 – volume: 59 start-page: 151417 year: 2021 ident: 2454_CR36 publication-title: Appl Nurs Res doi: 10.1016/j.apnr.2021.151417 |
| SSID | ssj0017853 |
| Score | 2.4472373 |
| SecondaryResourceType | review_article |
| Snippet | Frailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and impact of... Background Frailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and... BackgroundFrailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The prevalence and... Abstract Background Frailty has been increasingly identified as a risk factor of adverse outcomes in chronic obstructive pulmonary disease (COPD). The... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 164 |
| SubjectTerms | Care and treatment Chronic obstructive pulmonary disease Cross-Sectional Studies Development and progression Distribution Dyspnea Dyspnea - epidemiology Frail elderly Frailty Frailty - epidemiology Health aspects Humans Lung diseases Lung diseases, Obstructive Medical research Meta-analysis Mortality Obstructive lung disease Older people Prevalence Pulmonary Disease, Chronic Obstructive Pulmonology Quality of Life Respiration Respiratory function Risk factors Walking |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NaxUxEA_Sg3gRv12tEkHwIKGbj02yvdVqKYIfBwvvFmbzgQ_qPmm3B_vXd5Ldfb5F0IvXnQSSyczODDPzG0JeZxSlDhrP0H5IlhNxrONBMQ3RmK5JvPGl2uKzPj1TH1fNamfUV64JG-GBR8YdqGiCUSFKb0AlazuMu4WXIqGhse2IXoo2bw6mpvyBQSs0t8hYfXDJcz4Nz5NzlqpR7Hphhgpa_5__5B2jtCyY3LFAJ_fI3cl1pEfjke-TW7F_QG5_mpLjD8kqwzFBaSKi0Ac6Nz3SsROSbhJNF7A-H37RdU-Pv3x9f0iB_oZypmMbS9n7Iw7AYAIseUTOTj58Oz5l0-AE5rWsB2YakMJ2dWPB160IGtoowIoAHL0PjKgwzOIKdBs9tG1Sso74m7ESui7FJtXyMdnrN318SmgMAT1Io-rEk2qT7UAH9PJSCJynpENF-MxH5ydU8Tzc4tyV6MJqN_LeIe9d4b27rsjb7Z6fI6bGX1e_y8-zXZnxsMsHlBI3SYn7l5RU5E1-XJe1Fo_nYWo-wEtm_Ct3ZFSbZ05ZXZH9xUrUNr8kz-LhJm2_dMhNDMyUUKYir7bkvDNXsPVxc1XWoGuHwaWtyJNRmrZXkrkUwgik2IWcLe68pPTr7wULPAOuCW3aZ_-DS8_JHVF0pGFc7JO94eIqvkCfa-heFvW6AY08JiE priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NaxUxEA9aQbyI326tEkHwIKG7STbJepFaLUXw42Dh3UI2H_qg7tb3tof2rzeTzW67CL1ukiWZzCQzmZnfIPQGUJRaU1sS7w9GwBFH2spxIoyXsq1DVdsUbfFNHJ_wL6t6lR_ctjmscjoT00Htegtv5PtUgQONUy4_nP0lUDUKvKu5hMZtdAegy4Cr5Wo2uKDwPJsSZZTY31bgVYuzAs8lrzm5XFxGCbP__5P52tW0DJu8dg8dPUD3swKJD8Ydf4hu-e4Ruvs1u8gfoxWAMpmUSoRN5_CU-ojHfEjcBxw2Zn06XOB1hw-___j0Hht8BeiMx2SWNPaPHwwxGbbkCTo5-vzz8Jjk8gnEClYORNaGUdWWtTK2bKgTpvHUKOpMFXWQaFdFY6viRjTemqYJnJU-HjaKmbYNvg4le4p2ur7zzxH2zkU9UvIyVIE3QbVGuKjrBeeqKgThClRNdNQ2Y4tDiYtTnWwMJfRIex1prxPt9WWB3s1jzkZkjRt7f4TtmXsCKnb60G9-6SxkmnvpJHeeWWl4UKqVUX-zjIaolMT_1QV6C5urQXbj9KzJKQhxkYCCpQ8kb6DylBIF2lv0jDJnl80Te-gs81t9xaEFej03w0iIY-t8f576RAUvmpiqQM9GbpqXxCAgQtLYohZ8tljzsqVb_06I4AC7RoVsdm-e1wt0jybur0lF99DOsDn3L6NONbSvkuD8A762HjM priority: 102 providerName: ProQuest |
| Title | Prevalence and clinical impact of frailty in COPD: a systematic review and meta-analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37173728 https://www.proquest.com/docview/2815594247 https://www.proquest.com/docview/2813559668 https://pubmed.ncbi.nlm.nih.gov/PMC10182679 https://doaj.org/article/4e7d74de3c7a4f88b7612c32f1858905 |
| Volume | 23 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEB_6AeKL-G20HisIPkg0H_sVQaRXW4rQWooHhy_LZj_04Mzp9Qq2f72zm-TaYPHJlzxkd5Ps7MzOTGbnNwAvA4pSrZlJUX-UaQjEpXVuacq1E6JmPmcmnrY45ocT-mnKphvQlzvqCHh2o2sX6klNlvM3v39dfECBfx8FXvK3Z3mIluHbQkSSMppebsI2aiYRKhoc0auogkDd1CfO3DhuoJwihv_fO_U1VTU8RnlNLx3chTudQUl2Ww64BxuuuQ-3jrqQ-QOYBpAmHVOLiG4s6VMhSZsfSRae-KWezVcXZNaQvc8nH98RTa4Ankmb3BLH_nArneoOxuQhTA72v-wdpl05hdTwMlulgumykHXGpDZZVViuK1doWVido02CfhY6XznVvHJGV5WnZeZw85GlrmvvmM_KR7DVLBr3BIizFu1KQTOfe1p5WWtu0fbz1ua599wmkPd0VKbDGg8lL-Yq-hySq5b2CmmvIu3VZQKv12N-tkgb_-w9Dsuz7hlQsuONxfKb6oROUSesoNaVRmjqpawF2nOmLDwaKfg8lsCrsLgqcBd-ntFdSgJOMqBiqV1Bq1CJSvIEdgY9UQbNsLlnD9WzsEJqortGCyoSeLFuDiPDubbGLc5jHzT40OWUCTxuuWk9pTIckBAFtsgBnw3mPGxpZt8jQniAYSu4qJ7-Dyo9g9tFlBGW5sUObK2W5-45WmKregSbYipGsD3ePz45HcX_GaMocng9HX_9A1cuMto |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9QwDI_GkIAXxDeFAUEC8YCitWmapEgIjY1pYx_wsEn3lqVNAieN3ri7CW1_FH8jdtreViHtba9NUjWOHdu1_TMhbxBFqbJFzUB_5AwDcazKnGDSeqWqImRFHbMt9uXWofg6KkZL5G9fC4Nplf2dGC9qN6nxH_kq1xhAE1yoTye_GXaNwuhq30KjZYsdf_YHXLbZx-0NON-3nG9-OVjfYl1XAVbLPJ0zVdic6yottK3TkjtpS8-t5s5moJrB3QAfJBNWlr62ZRlEnnqQQZ3bqgq-CGkO771BboLiTdHZU6OFg4eN7vO-MEfL1VmGUTygAkZKRSHY-UD5xR4B_2uCS6pwmKZ5Se9t3iN3O4OVrrUcdp8s-eYBubXXheQfkhGCQNlYukRt42hfaknb-ks6CTRM7fh4fkbHDV3_9n3jA7X0AkCatsUzce0vP7fMdjApj8jhtRD2MVluJo1_Sqh3DuxWJdKQBVEGXVnpwLYMzmVZCNIlJOvpaOoOyxxbahyb6NNoaVraG6C9ibQ35wl5v1hz0iJ5XDn7Mx7PYiaicMcHk-kP0wm1EV45JZzPa2VF0LpSYC_WOQ9gBMH7ioS8w8M1eFfA59W2K3mATSLqlllTosROV1omZGUwE2S8Hg737GG6O2ZmLiQiIa8Xw7gS8-YaPzmNc8CgBJdWJ-RJy02LLeWYgKE4jOgBnw32PBxpxj8jAjnCvHGpymdXf9crcnvrYG_X7G7v7zwnd3iUhIJlfIUsz6en_gXYc_PqZRQiSo6uW2r_AY-WWhQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+and+clinical+impact+of+frailty+in+COPD%3A+a+systematic+review+and+meta-analysis&rft.jtitle=BMC+pulmonary+medicine&rft.au=Lina+Wang&rft.au=Xiaolin+Zhang&rft.au=Xinmin+Liu&rft.date=2023-05-12&rft.pub=BMC&rft.eissn=1471-2466&rft.volume=23&rft.issue=1&rft.spage=1&rft.epage=12&rft_id=info:doi/10.1186%2Fs12890-023-02454-z&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_4e7d74de3c7a4f88b7612c32f1858905 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2466&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2466&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2466&client=summon |